A potent and highly selective nonpeptidyl nociceptin/orphanin FQ receptor (ORL1) antagonist: J-113397

By Ozaki S.   Kawamoto H.   Itoh Y.   Miyaji M.   Iwasawa Y.   Ohta H.  

European Journal of Pharmacology, Vol. 387, Iss. 3, 2000-01 ,pp. : 17-18

Elsevier

Access to resources Recommend Favorite

Antinociceptive effects of the ORL1 receptor agonist nociceptin/orphanin FQ in diabetic mice

By Kamei J.   Ohsawa M.   Kashiwazaki T.   Nagase H.  

European Journal of Pharmacology, Vol. 370, Iss. 2, 1999-04 ,pp. : 109-116

Elsevier

Access to resources Recommend Favorite

Recognition and activation of the opioid receptor-like ORL1 receptor by nociceptin, nociceptin analogs and opioids

By Butour J.-L.   Moisand C.   Mazarguil H.   Mollereau C.   Meunier J.-C.  

European Journal of Pharmacology, Vol. 321, Iss. 1, 1997-02 ,pp. : 97-103

Elsevier

Access to resources Recommend Favorite

Antidepressant-like effects of the nociceptin/orphanin FQ receptor antagonist UFP-101: new evidence from rats and mice

By Gavioli E.   Vaughan C.   Marzola G.   Guerrini R.   Mitchell V.   Zucchini S.   Lima T.   Rae G.   Salvadori S.   Regoli D.   Calo’ G.  

Naunyn-Schmiedeberg's Archives of Pharmacology, Vol. 369, Iss. 6, 2004-06 ,pp. : 547-553

Springer Publishing Company

Access to resources Recommend Favorite

Nociceptin/Orphanin FQ Peptide Receptor as a Therapeutic Target for Obesity

By  

Mini Reviews in Medicinal Chemistry, Vol. 8, Iss. 8, 2008-07 ,pp. : 796-811

Bentham Science Publishers

Access to resources Recommend Favorite